newsfilter
← Latest News
GlobeNewswire·

DMK Pharmaceuticals Announces Inducement Option Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Oct. 20, 2023 (GLOBE NEWSWIRE) -- DMK Pharmaceuticals Corporation (NASDAQ:DMK), a commercial-stage biopharmaceutical company, today announced that the compensation committee of the board of directors